Comparison of clinical risk assessment systems in predicting three-vessel coronary artery disease and angiographic culprit lesion in patients with non-ST segment elevated myocardial infarction/unstable angina pectoris

Kardiologia Polska

Volumn 70, Issue 3, 2012, Pages 242-250

  Isilak, Zafer ^a   Kardesoglu, Ejder ^a   Aparci, Mustafa ^a   Uz, Omer ^a   Yalcin, Murat ^a   Yiginer, Omer ^a   Cingozbay, Bekir Yilmaz ^a   Uzun, Mehmet ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Acute coronary syndrome; Culprit lesion; Risk score; Three vessel disease

Indexed keywords

C REACTIVE PROTEIN; HEART ENZYME;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS;

EID: 84859052503     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol, 2000; 36: 970-1062
2. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol, 2002; 40: 1366.
3. Wexler L, Brundage B, Crouse J et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation, 1996; 94: 1175-1192.
4. Anderson HV, Cannon CP, Stone PH et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol, 1995; 26: 1643-1650.
5. Cannon CP. Evidence-based risk stratification totarget therapies in acute coronary syndromes. Circulation, 2002; 106: 1588-1591.
6. Wiviott SD, Braunwald E. Unstable angina and non-ST-segment elevation myocardial infarction: part i. initial evaluation and management, and hospital care. Am Fam Physician, 2004;70: 525-532. (Pubitemid 39045563)
7. Rizik DG, Healy S, Margulis A. New clinical classification unstable angina pectoris. Am J Cardiol, 1995; 75: 993-997.
8. Antman EM, Cohen M, Bernink PJ et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA, 2000; 284:835-842. (Pubitemid 30643610)
9. Sabatine MS, Antman EM et al. The thrombolysis in myocardial infarction risk score in unstable angina pectoris/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol, 2003; 41: 89S-95S. (Pubitemid 36223352)
10. Simoons ML, GUSTO IV-ACS Investigators. Effect of glycoprotein 2b/3a receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: The GUSTO 4-ACS randomised trial. Lancet, 2001;357: 1915-1924. (Pubitemid 32568331)
11. Boersma E, Pieper KS, Steyerberg EW et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients.The PURSUITS Investigators. Circulation, 2000; 101: 2557.
12. Pedro de Araujo G, Jorge F, Carlos A et al. TIMI, PURSUIT and GRACE risc scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005; 26: 865-872.
13. Granger CB, Goldberg RJ, Dabbous O et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med, 2003; 163: 2345.
14. Kurz DJ, Bernstein A, Hunt K et al. Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model. Heart, 2009; 95: 662-668.
15. Beygui F, Silvain J, Pena A et al. Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Am J Cardiol, 2010; 106: 650-658.
16. Huang G, Zhao J-L, Du H et al. Coronary score adds prognostic information for patients with acute coronary syndrome. Circulation, 2010; 74: 490-495.
17. Zhong B, Liu Z, Su L et al. Comparison of prognostic value of different risk score methods on outcome of acute coronary syndrome. Clin Cardiol, 2009; 32: 434-438.
18. Antman EM, McCabe CH, Gurfinkel EP et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina//non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation, 1999;100: 1593-1601.
19. Mega JL, Morrow DA, Sabatine MS et al. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J, 2005; 149: 846-850. (Pubitemid 40718880)
20. Garcia S, Canoniero M, Peter A et al. Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol, 2004; 93: 813-816. (Pubitemid 38429588)
21. Lakhani MS, Qadir F, Hanif B et al. Correlation of thrombolysis in myocardial infarction (TIMI) risk score with extent of coronary artery disease in patients with acute coronary syndrome. J Pak Med Assoc, 2010; 60: 197-200.
22. Brilakis ES, Wright RS, Kopecky SL et al. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J, 2003; 146: 811-818. (Pubitemid 37378569)
23. Sanchais J, Bodi, V, Llacer A et al. Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome. Rev Esp Cardiol, 2004; 57: 382-387. (Pubitemid 38787222)
24. Magalhães CK, Siqueira Filho AG, Amino JG et al. Correlation between biochemical markers and coronary angiography in patients with non-ST elevation acute coronary syndromes. Arq Bras Cardiol, 2006; 86: 223-231.